NASH
Clinical trials for NASH explained in plain language.
Never miss a new study
Get alerted when new NASH trials appear
Sign up with your email to follow new studies for NASH, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial targets silent liver disease
Disease control CompletedThis study tested whether a drug called elobixibat could help adults with fatty liver disease (NAFLD or NASH). Forty-seven participants were randomly assigned to receive either the drug or a placebo for 16 weeks. Researchers measured changes in liver fat, cholesterol levels, and …
Matched conditions: NASH
Phase: PHASE2 • Sponsor: Albireo • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Could a blood test replace a liver biopsy for diabetes patients?
Diagnosis CompletedThis study aimed to see if two simple blood tests (called eLIFT and FibroMeter) could accurately screen for advanced liver scarring (fibrosis) in people with type 2 diabetes. It involved 722 participants with type 2 diabetes and a higher body weight. The results of the blood test…
Matched conditions: NASH
Phase: NA • Sponsor: Nantes University Hospital • Aim: Diagnosis
Last updated Mar 05, 2026 14:00 UTC